![Wendy Chan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Wendy Chan
Algemeen Directeur bij LODE GOLD RESOURCES INC.
Vermogen: 59 600 $ op 31-05-2024
Profiel
Wendy T.
Chan is the founder of Moxie Strategy, Inc., Care Point Medical & Wellness Clinics.
She currently holds the position of Chief Executive Officer & Director at Lode Gold Resources, Inc. since 2023, Independent Director at Riverside Resources, Inc. since 2022, and Director at Mandala Capital, Inc. since 2022.
Previously, she worked as a Business Director at Johnson & Johnson, Janssen Pharmaceuticals, Inc., Aurora Cannabis, Inc., GlaxoSmithKline, Inc., and Janssen, Inc. She also served as a Director at Bc Cancer Foundation and held the position of Business Director at NexGen Hearing.
Additionally, she worked as the Vice President-Corporate Development at Skeena Resources Ltd.
Ms. Chan completed her MBA from McGill University and holds an undergraduate degree from the University of British Columbia.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
MANDALA CAPITAL INC
6.15% | 10-02-2023 | 560 000 ( 6.15% ) | 30 800 $ | 31-05-2024 |
LODE GOLD RESOURCES INC
0.25% | 04-03-2024 | 900 000 ( 0.25% ) | 28 800 $ | 31-05-2024 |
RIVERSIDE RESOURCES INC.
-.--% | 17-01-2024 | 0 ( -.--% ) | - $ | 31-05-2024 |
Actieve functies van Wendy Chan
Bedrijven | Functie | Begin |
---|---|---|
MANDALA CAPITAL INC. | Directeur/Bestuurslid | 01-05-2022 |
RIVERSIDE RESOURCES INC. | Directeur/Bestuurslid | 01-03-2022 |
LODE GOLD RESOURCES INC. | Algemeen Directeur | 19-12-2023 |
Eerdere bekende functies van Wendy Chan
Bedrijven | Functie | Einde |
---|---|---|
Bc Cancer Foundation | Directeur/Bestuurslid | - |
AURORA CANNABIS INC. | Corporate Officer/Principal | - |
NexGen Hearing
![]() NexGen Hearing Medical SpecialtiesHealth Technology NexGen Hearing provides hearing healthcare products and services. | Corporate Officer/Principal | - |
Janssen, Inc.
![]() Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Corporate Officer/Principal | - |
GlaxoSmithKline, Inc.
![]() GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - |
Opleiding van Wendy Chan
University of British Columbia | Undergraduate Degree |
McGill University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 6 |
---|---|
SKEENA RESOURCES LIMITED | Non-Energy Minerals |
MANDALA CAPITAL INC. | Finance |
JOHNSON & JOHNSON | Health Technology |
AURORA CANNABIS INC. | Process Industries |
RIVERSIDE RESOURCES INC. | Non-Energy Minerals |
LODE GOLD RESOURCES INC. | Non-Energy Minerals |
Bedrijven in privébezit | 7 |
---|---|
Moxie Strategy, Inc. | |
Care Point Medical & Wellness Clinics | |
Janssen Pharmaceuticals, Inc.
![]() Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
Janssen, Inc.
![]() Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Health Technology |
GlaxoSmithKline, Inc.
![]() GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
NexGen Hearing
![]() NexGen Hearing Medical SpecialtiesHealth Technology NexGen Hearing provides hearing healthcare products and services. | Health Technology |
Bc Cancer Foundation |